Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Overexpression of the DOF-Type Transcription Factor Enhances Lipid Synthesis in Chlorella vulgaris.

Tokunaga S, Sanda S, Uraguchi Y, Nakagawa S, Sawayama S.

Appl Biochem Biotechnol. 2019 Sep;189(1):116-128. doi: 10.1007/s12010-019-02990-7. Epub 2019 Mar 16.

PMID:
30877635
2.

Survival in a bad neighborhood: pancreatic islets in cystic fibrosis.

Norris AW, Ode KL, Merjaneh L, Sanda S, Yi Y, Sun X, Engelhardt JF, Hull RL.

J Endocrinol. 2019 Feb 1. pii: JOE-18-0468.R1. doi: 10.1530/JOE-18-0468. [Epub ahead of print] Review.

PMID:
30759072
3.

Hyaluronan levels are increased systemically in human type 2 but not type 1 diabetes independently of glycemic control.

Nagy N, Sunkari VG, Kaber G, Hasbun S, Lam DN, Speake C, Sanda S, McLaughlin TL, Wight TN, Long SR, Bollyky PL.

Matrix Biol. 2019 Jul;80:46-58. doi: 10.1016/j.matbio.2018.09.003. Epub 2018 Sep 6.

PMID:
30196101
4.

Islet Interleukin-1β Immunoreactivity Is an Early Feature of Cystic Fibrosis That May Contribute to β-Cell Failure.

Hull RL, Gibson RL, McNamara S, Deutsch GH, Fligner CL, Frevert CW, Ramsey BW, Sanda S.

Diabetes Care. 2018 Apr;41(4):823-830. doi: 10.2337/dc17-1387. Epub 2018 Feb 1.

5.

Enzymatic degradation of β-1,4-linked N-acetylglucosaminoglucan prepared from Thiothrix nivea.

Takeda M, Kondo K, Sanda S, Kan D, Borges IK, Suzuki I, Katahira M.

Int J Biol Macromol. 2018 Apr 1;109:323-328. doi: 10.1016/j.ijbiomac.2017.12.065. Epub 2017 Dec 15.

PMID:
29253548
6.

Is mass drug administration against lymphatic filariasis required in urban settings? The experience in Kano, Nigeria.

Pam DD, de Souza DK, D'Souza S, Opoku M, Sanda S, Nazaradden I, Anagbogu IN, Okoronkwo C, Davies E, Elhassan E, Molyneux DH, Bockarie MJ, Koudou BG.

PLoS Negl Trop Dis. 2017 Oct 11;11(10):e0006004. doi: 10.1371/journal.pntd.0006004. eCollection 2017 Oct.

7.

Remodeling T cell compartments during anti-CD3 immunotherapy of type 1 diabetes.

Long SA, Thorpe J, Herold KC, Ehlers M, Sanda S, Lim N, Linsley PS, Nepom GT, Harris KM.

Cell Immunol. 2017 Sep;319:3-9. doi: 10.1016/j.cellimm.2017.07.007. Epub 2017 Aug 18.

8.

Increasing ICA512 autoantibody titers predict development of abnormal oral glucose tolerance tests.

Sanda S; Type 1 Diabetes TrialNet Study Group.

Pediatr Diabetes. 2018 Mar;19(2):271-276. doi: 10.1111/pedi.12542. Epub 2017 Jul 14.

9.

Overexpression of DnaJ-Like Chaperone Enhances Carotenoid Synthesis in Chlamydomonas reinhardtii.

Morikawa T, Uraguchi Y, Sanda S, Nakagawa S, Sawayama S.

Appl Biochem Biotechnol. 2018 Jan;184(1):80-91. doi: 10.1007/s12010-017-2521-5. Epub 2017 Jun 13.

PMID:
28612271
10.

Acute hyperglycemia impairs IL-6 expression in humans.

Spindler MP, Ho AM, Tridgell D, McCulloch-Olson M, Gersuk V, Ni C, Greenbaum C, Sanda S.

Immun Inflamm Dis. 2016 Jan 19;4(1):91-7. doi: 10.1002/iid3.97. eCollection 2016 Mar.

11.

A Copper-Based Metal-Organic Framework Acts as a Bifunctional Catalyst for the Homocoupling of Arylboronic Acids and Epoxidation of Olefins.

Parshamoni S, Telangae J, Sanda S, Konar S.

Chem Asian J. 2016 Feb 18;11(4):540-7. doi: 10.1002/asia.201501084. Epub 2016 Jan 7.

PMID:
26629650
12.

Proton-Conducting Magnetic Coordination Polymers.

Biswas S, Jena HS, Sanda S, Konar S.

Chemistry. 2015 Sep 21;21(39):13793-801. doi: 10.1002/chem.201501526. Epub 2015 Aug 13.

PMID:
26274020
13.

Highly selective detection of palladium and picric acid by a luminescent MOF: a dual functional fluorescent sensor.

Sanda S, Parshamoni S, Biswas S, Konar S.

Chem Commun (Camb). 2015 Apr 18;51(30):6576-9. doi: 10.1039/c4cc10442k.

PMID:
25772382
14.

Study of proton conductivity of a 2D flexible MOF and a 1D coordination polymer at higher temperature.

Sanda S, Biswas S, Konar S.

Inorg Chem. 2015 Feb 16;54(4):1218-22. doi: 10.1021/ic502098h. Epub 2015 Jan 16.

PMID:
25594401
15.

Tuning CO2 uptake and reversible iodine adsorption in two isoreticular MOFs through ligand functionalization.

Parshamoni S, Sanda S, Jena HS, Konar S.

Chem Asian J. 2015 Mar;10(3):653-60. doi: 10.1002/asia.201403123. Epub 2014 Dec 18.

PMID:
25523149
16.

A perception of ferro- and antiferromagnetic interactions in a two dimensional Ni(II) heterochiral coordination polymer showing unusual CO₂ uptake behavior.

Jena HS, Goswami S, Sanda S, Parshamoni S, Biswas S, Konar S.

Dalton Trans. 2014 Dec 7;43(45):16996-9. doi: 10.1039/c4dt02496f.

PMID:
25325616
17.

Effect of smoking cessation on non-surgical periodontal therapy: results after 24 months.

Rosa EF, Corraini P, Inoue G, Gomes EF, Guglielmetti MR, Sanda SR, Lotufo JP, Romito GA, Pannuti CM.

J Clin Periodontol. 2014 Dec;41(12):1145-53. doi: 10.1111/jcpe.12313. Epub 2014 Nov 21.

PMID:
25265872
18.

Ocular morbidity and health seeking behaviour in Kwara state, Nigeria: implications for delivery of eye care services.

Senyonjo L, Lindfield R, Mahmoud A, Kimani K, Sanda S, Schmidt E.

PLoS One. 2014 Aug 28;9(8):e104128. doi: 10.1371/journal.pone.0104128. eCollection 2014. Erratum in: PLoS One. 2014;9(10):e112860.

19.

Avidity-dependent programming of autoreactive T cells in T1D.

Durinovic-Belló I, Gersuk VH, Ni C, Wu R, Thorpe J, Jospe N, Sanda S, Greenbaum CJ, Nepom GT.

PLoS One. 2014 May 20;9(5):e98074. doi: 10.1371/journal.pone.0098074. eCollection 2014.

20.

A copper based pillared-bilayer metal organic framework: its synthesis, sorption properties and catalytic performance.

Parshamoni S, Sanda S, Jena HS, Konar S.

Dalton Trans. 2014 May 21;43(19):7191-9. doi: 10.1039/c4dt00228h. Epub 2014 Mar 28.

PMID:
24676502
21.

Third-generation breathing metal-organic framework with selective, stepwise, reversible, and hysteretic adsorption properties.

Sanda S, Parshamoni S, Konar S.

Inorg Chem. 2013 Nov 18;52(22):12866-8. doi: 10.1021/ic402095u. Epub 2013 Oct 30.

PMID:
24171473
22.

Use of a "fuzzy logic" controller in a closed-loop artificial pancreas.

Mauseth R, Hirsch IB, Bollyky J, Kircher R, Matheson D, Sanda S, Greenbaum C.

Diabetes Technol Ther. 2013 Aug;15(8):628-33. doi: 10.1089/dia.2013.0036. Epub 2013 Jul 5.

PMID:
23829285
23.

Evaluation of in vivo T cell kinetics: use of heavy isotope labelling in type 1 diabetes.

Bollyky JB, Long SA, Fitch M, Bollyky PL, Rieck M, Rogers R, Samuels PL, Sanda S, Buckner JH, Hellerstein MK, Greenbaum CJ.

Clin Exp Immunol. 2013 Jun;172(3):363-74. doi: 10.1111/cei.12064.

24.

Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials.

Moran A, Bundy B, Becker DJ, DiMeglio LA, Gitelman SE, Goland R, Greenbaum CJ, Herold KC, Marks JB, Raskin P, Sanda S, Schatz D, Wherrett DK, Wilson DM, Krischer JP, Skyler JS; Type 1 Diabetes TrialNet Canakinumab Study Group, Pickersgill L, de Koning E, Ziegler AG, Böehm B, Badenhoop K, Schloot N, Bak JF, Pozzilli P, Mauricio D, Donath MY, Castaño L, Wägner A, Lervang HH, Perrild H, Mandrup-Poulsen T; AIDA Study Group.

Lancet. 2013 Jun 1;381(9881):1905-15. doi: 10.1016/S0140-6736(13)60023-9. Epub 2013 Apr 5.

25.

CD4+ T cells recognize diverse epitopes within GAD65: implications for repertoire development and diabetes monitoring.

Yang J, James EA, Sanda S, Greenbaum C, Kwok WW.

Immunology. 2013 Mar;138(3):269-79. doi: 10.1111/imm.12034.

26.

Niger's success in child survival.

Sanda S.

Lancet. 2012 Sep 29;380(9848):1127-8. doi: 10.1016/S0140-6736(12)61514-1. Epub 2012 Sep 20. No abstract available.

PMID:
22999431
27.

Rapamycin/IL-2 combination therapy in patients with type 1 diabetes augments Tregs yet transiently impairs β-cell function.

Long SA, Rieck M, Sanda S, Bollyky JB, Samuels PL, Goland R, Ahmann A, Rabinovitch A, Aggarwal S, Phippard D, Turka LA, Ehlers MR, Bianchine PJ, Boyle KD, Adah SA, Bluestone JA, Buckner JH, Greenbaum CJ; Diabetes TrialNet and the Immune Tolerance Network.

Diabetes. 2012 Sep;61(9):2340-8. doi: 10.2337/db12-0049. Epub 2012 Jun 20.

28.

Review of the publications of the Nigeria national blindness survey: methodology, prevalence, causes of blindness and visual impairment and outcome of cataract surgery.

Rabiu MM, Kyari F, Ezelum C, Elhassan E, Sanda S, Murthy GV, Sivasubramaniam S, Glibert C, Abdull MM, Abiose A, Bankole O, Entekume G, Faal H, Imam A, Sang LP, Abubakar T.

Ann Afr Med. 2012 Jul-Sep;11(3):125-30. doi: 10.4103/1596-3519.96859. Review.

29.

Through the fog: recent clinical trials to preserve β-cell function in type 1 diabetes.

Greenbaum CJ, Schatz DA, Haller MJ, Sanda S.

Diabetes. 2012 Jun;61(6):1323-30. doi: 10.2337/db11-1452. Review. No abstract available.

30.

A SNP in G6PC2 predicts insulin secretion in type 1 diabetes.

Sanda S, Wei S, Rue T, Shilling H, Greenbaum C.

Acta Diabetol. 2013 Jun;50(3):459-62. doi: 10.1007/s00592-012-0389-y. Epub 2012 Mar 22.

PMID:
22438186
31.

Correlation of TSH with the risk of paediatric thyroid carcinoma.

Chiu HK, Sanda S, Fechner PY, Pihoker C.

Clin Endocrinol (Oxf). 2012 Aug;77(2):316-22. doi: 10.1111/j.1365-2265.2012.04383.x.

PMID:
22404106
32.

Diabetes promotes an inflammatory macrophage phenotype and atherosclerosis through acyl-CoA synthetase 1.

Kanter JE, Kramer F, Barnhart S, Averill MM, Vivekanandan-Giri A, Vickery T, Li LO, Becker L, Yuan W, Chait A, Braun KR, Potter-Perigo S, Sanda S, Wight TN, Pennathur S, Serhan CN, Heinecke JW, Coleman RA, Bornfeldt KE.

Proc Natl Acad Sci U S A. 2012 Mar 20;109(12):E715-24. doi: 10.1073/pnas.1111600109. Epub 2012 Jan 17.

33.

Discovery of T cell antigens by high-throughput screening of synthetic minigene libraries.

Hondowicz BD, Schwedhelm KV, Kas A, Tasch MA, Rawlings C, Ramchurren N, McIntosh M, D'Amico LA, Sanda S, Standifer NE, Shendure J, Stone B.

PLoS One. 2012;7(1):e29949. doi: 10.1371/journal.pone.0029949. Epub 2012 Jan 12.

34.

Altered B cell homeostasis is associated with type I diabetes and carriers of the PTPN22 allelic variant.

Habib T, Funk A, Rieck M, Brahmandam A, Dai X, Panigrahi AK, Luning Prak ET, Meyer-Bahlburg A, Sanda S, Greenbaum C, Rawlings DJ, Buckner JH.

J Immunol. 2012 Jan 1;188(1):487-96. doi: 10.4049/jimmunol.1102176. Epub 2011 Nov 21.

35.

Clinical trial of extended-dose chloroquine for treatment of resistant falciparum malaria among Afghan refugees in Pakistan.

Howard N, Durrani N, Sanda S, Beshir K, Hallett R, Rowland M.

Malar J. 2011 Jun 23;10:171. doi: 10.1186/1475-2875-10-171.

36.
37.

Responses of the photosynthetic electron transport system to excess light energy caused by water deficit in wild watermelon.

Sanda S, Yoshida K, Kuwano M, Kawamura T, Munekage YN, Akashi K, Yokota A.

Physiol Plant. 2011 Jul;142(3):247-64. doi: 10.1111/j.1399-3054.2011.01473.x. Epub 2011 Apr 29.

PMID:
21438881
38.

Short-term IL-1beta blockade reduces monocyte CD11b integrin expression in an IL-8 dependent fashion in patients with type 1 diabetes.

Sanda S, Bollyky J, Standifer N, Nepom G, Hamerman JA, Greenbaum C.

Clin Immunol. 2010 Aug;136(2):170-3. doi: 10.1016/j.clim.2010.04.009. Epub 2010 May 18.

PMID:
20483667
39.

Insulin gene VNTR genotype associates with frequency and phenotype of the autoimmune response to proinsulin.

Durinovic-Belló I, Wu RP, Gersuk VH, Sanda S, Shilling HG, Nepom GT.

Genes Immun. 2010 Mar;11(2):188-93. doi: 10.1038/gene.2009.108. Epub 2010 Jan 7.

40.

Defects in IL-2R signaling contribute to diminished maintenance of FOXP3 expression in CD4(+)CD25(+) regulatory T-cells of type 1 diabetic subjects.

Long SA, Cerosaletti K, Bollyky PL, Tatum M, Shilling H, Zhang S, Zhang ZY, Pihoker C, Sanda S, Greenbaum C, Buckner JH.

Diabetes. 2010 Feb;59(2):407-15. doi: 10.2337/db09-0694. Epub 2009 Oct 29.

41.

Functional islet-specific Treg can be generated from CD4+CD25- T cells of healthy and type 1 diabetic subjects.

Long SA, Walker MR, Rieck M, James E, Kwok WW, Sanda S, Pihoker C, Greenbaum C, Nepom GT, Buckner JH.

Eur J Immunol. 2009 Feb;39(2):612-20. doi: 10.1002/eji.200838819.

42.

The effector T cells of diabetic subjects are resistant to regulation via CD4+ FOXP3+ regulatory T cells.

Schneider A, Rieck M, Sanda S, Pihoker C, Greenbaum C, Buckner JH.

J Immunol. 2008 Nov 15;181(10):7350-5.

43.

Type 1 diabetes mellitus: primary, secondary, and tertiary prevention.

Bollyky J, Sanda S, Greenbaum CJ.

Mt Sinai J Med. 2008 Aug;75(4):385-97. doi: 10.1002/msj.20054. Review.

PMID:
18729155
44.
45.

Islet antigen specific IL-10+ immune responses but not CD4+CD25+FoxP3+ cells at diagnosis predict glycemic control in type 1 diabetes.

Sanda S, Roep BO, von Herrath M.

Clin Immunol. 2008 May;127(2):138-43. doi: 10.1016/j.clim.2007.12.003. Epub 2008 Mar 4.

PMID:
18304876
46.
47.

Type 1 diabetes as a relapsing-remitting disease?

von Herrath M, Sanda S, Herold K.

Nat Rev Immunol. 2007 Dec;7(12):988-94. Review.

PMID:
17982429
48.

Characterization of cytochrome P450-mediated drug metabolism in cats.

Shah SS, Sanda S, Regmi NL, Sasaki K, Shimoda M.

J Vet Pharmacol Ther. 2007 Oct;30(5):422-8.

PMID:
17803734
49.

The heart failure revascularisation trial (HEART): rationale, design and methodology.

Cleland JG, Freemantle N, Ball SG, Bonser RS, Camici P, Chattopadhyay S, Dutka D, Eastaugh J, Hampton J, Large S, Norell MS, Pennell DJ, Pepper J, Sanda S, Senior R, Smith D.

Eur J Heart Fail. 2003 Jun;5(3):295-303. Review.

50.

Recombinant Arabidopsis SQD1 converts udp-glucose and sulfite to the sulfolipid head group precursor UDP-sulfoquinovose in vitro.

Sanda S, Leustek T, Theisen MJ, Garavito RM, Benning C.

J Biol Chem. 2001 Feb 9;276(6):3941-6. Epub 2000 Nov 9.

Supplemental Content

Support Center